Abstract
This study aimed to evaluate the anti-hypothyroidism potential of ashwagandha methanolic extract (AME). This target was performed through induction of animal model of hypothyroidism by propylthiouracil. After 1 month from treatments, blood samples were collected for biochemical determinations, and liver and kidney were removed for the determination of oxidative stress markers and thyroid gland was removed for histopathological examination. The total phenolic compounds in the extract and the in vitro radical scavenging activity of extract were also determined. The results revealed that the induction of hypothyroidism by propylthiouracil induced a significant increase in serum TSH level but it induced significant decreases in the levels of total T3, free T3, free T4, and total T4 hormones compared with the control values. Also, serum glucose, Il-6, and body weight gain increased significantly while Il-10 and blood hemoglobin levels showed significant decrease. Induction of hypothyroidism increased also the levels of hepatic and renal MDA and NO and decreased significantly the values of GSH, GPx and Na+/ K+-ATPase. Both AME and the anti-hypothyroidism drug significantly ameliorated the changes occurred in the levels of the above parameters and improved histological picture of thyroid gland but with different degrees; where ashwagandha methanolic extract showed the strongest effect. We can conclude that ashwagandha methanolic extract treatment improves thyroid function by ameliorating thyroid hormones and by preventing oxidative stress.
Similar content being viewed by others
References
Kim B (2008) Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 18(2):141–144
Cachefo A,N,A, Boucher P, Vidon C, Dusserre E, Diraison F, Beylot M (2001) Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab 86(11):5353–5357
Saleh AB (2015) Lipid profile and levels of homocysteine and total antioxidant capacity in plasma of rats with experimental thyroid disorders. J Basic Appl Zool 72:173–178
Ahmad S, Geraci SA, Koch CA (2013) Thyroid disease in pregnancy: (Women’s Health Series). South Med J 106:532–538
Tirosh D, Benshalom-Tirosh N, Novack L, Press F, Beer-Weisel R, Wiznitzer A, Mazor M, Erez O (2013) Hypothyroidism and diabetes mellitus—a risky dual gestational indocrinopathy. PeerJ 1:1–52
Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK (2013) Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab 98:2725–2733
Sharma S, Joshi A, Hemalatha S (2017) Protective effect of Withania coagulans fruit extract on cisplatin-induced nephrotoxicity in rats. Pharmacogn Res 9(4):354–361
Srivastava S, Singh R, Srivastava G, Sharma A (2018) Comparative study of Withanolide biosynthesis-related miRNAs in root and leaf tissues of Withania somnifera. Appl Biochem Biotechnol 185:1145–1159
Oza VP, Parmar PP, Kumar S, Subramanian RB (2010) anticancer properties of highly purified L-Asparaginase from Withania somnifera L. against acute lymphoblastic leukemia. Appl Biochem Biotechnol 160:1833–1840
Bhattacharya SK, Muruganandam AV (2003) Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75(3):547–555
Devkar ST, Kandhare AD, Zanwar AA, Jagtap SD, Katyare SS, Bodhankar SL, Hegde MV (2016) Hepatoprotective effect of withanolide-rich fraction in acetaminophen-intoxicated rat: decisive role of TNF-α, IL-1β, COX-II and iNOS. Pharm Biol 54(11):2394–2403
Hoda Q, Ahmad S, Akhtar M, Najmi AK, Pillai KK, Ahmad S,J (2010) Antihyperglycaemic and antihyperlipidaemic effect of poly-constituents, in aqueous and chloroform extracts, of Withania coagulans Dunal in experimental type 2 diabetes mellitus in rats. Hum Exp Toxicol 29(8):653–658
Saxena B (2010) Anti-hyperlipidemic activity of Withania coagulans in streptozotocin-induced diabetes: a potent anti-atherosclerotic agent. Drug Discov Ther 4:334–340
Ganesan K, Sehgal PK, Mandal AB, Sayeed S (2011) Protective effect of Withania somnifera and Cardiospermum halicacabum extracts against collagenolytic degradation of collagen. Appl Biochem Biotechnol 165:1075–1091
Jayaprakasha GK, Tamil S, Sakariah KK (2003) Antibacterial and antioxidant activities of grape (Vitis vinifera) seed extracts. Food Res Int 36(2):117–122
Nogala-Kalucka M, Korczak J, Dratwia M, Lampart-Szczapa E, Siger A, Buchowski M (2005) Changes in antioxidant activity and free radical scavenging potential of rosemary extract and tocopherols in isolated rapeseed oil triacylglycerols during accelerated tests. Food Chem 93:227–235
Rajasekar S, Elango R (2011) Estimation of alkaloid content of ashwagandha (Withania somnifera) with HPLC methods. J Exp Sci 2(5):39–41
Trivedi MK, Branton A, Trivedi D, Nayak G et al (2017) Liquid chromatography–mass spectrometry (LC-MS) analysis of Withania somnifera (ashwagandha) root extract treated with the energy of consciousness. Am J Quantum Chem Mol Spectrosc 1(1):21–30
Sahoo D, Roy A, Bhanja S, Chainy G (2008) Hypothyroidism impairs antioxidant defense system and testicular physiology during development and maturation. Gen Comp Endocrinol 156(1):63–70
Sultana N, Shimmi SC, Parash MTH, Akhtar J (2012) Effects of ashwagandha (Withania somnifera) root extract on some serum liver marker enzymes (AST, ALT) in gentamicin intoxicated rats. J Bangladesh Soc Physiol 7(1):1–7
Kuznetsova LA, Derkach KV, Sharova TS, Bondareva VM, Shpakov AO (2015) Effect of long-term L-thyroxine treatment on the activity of NO-synthases in tissues of rats with obesity induced by high-fat diet. J Evol Biochem Physiol 51:485–494
Drury RA, Wallington EA (1980) Carleton’s histological technique, 5th edn. Oxford University Press, New York
RuizLarnea MB, Leal AM, Liza M, Lacort M, de Groot H (1994) Antioxidant effects of estradiol and 2 hydroxyestradiol on iron induced lipid peroxidation of rat liver microsome. Steriod 59:383388
Tsakiris S, Angelogianni P, Schulpis KH, Belrakis P (2000) Protective effect of L-cysteine and glutathione on rat brain Na+/K+-ATPase inhibition induced by free radical. Z Naturforsch 55:271–277
Sener G, Kabasakal L, Atasoy BM, Erzik C, Velioğlu-Oğünç A, Cetinel S, Contuk G, Gedik N, Yeğen BC (2006) Propylthiouracil-induced hypothyroidism protects ionizing radiation-induced multiple organ damage in rats. J Endocrinol 189:257–269
Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, Xinaris C, Cokkinos AD, Carageorgiou H, Varonos DD, Cokkinos DV (2003) Propylthiouracil-induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischaemia-reperfusion. J Endocrinol 178:427–435
Zhang L, Blomgren K, Kuhn HG, Cooper-Kuhn CM (2009) Effects of postnatal thyroid hormone deficiency on neurogenesis in the juvenile and adult rat. Neurobiol Dis 34(2):366–374
Umezu M, Kagabu S, Jiang J, Sato E (1998) Evaluation and characterization of congenital hypothyroidism in rdw dwarf rats. Lab Anim Sci 48(5):496–501
Fumarola A, Di Fiore A, Dainelli M, Grani G, Calvanese A (2010) Medical treatment of hyperthyroidism: state of the art. Exp Clin Endocrinol 118:678–684
Sue M, Akama T, Kawashima A, Nakamura H, Hara T, Tanigawa K, Wu H, Yoshihara A, Ishido Y, Hiroi N, Yoshino G, Kohn LD, Ishii N, Suzuki K (2012) Propylthiouracil increases sodium/iodide symporter gene expression and iodide uptake in rat thyroid cells in the absence of TSH. Thyroid 22(8):844–852
Chakrabarti SK, Ghosh S, Banerjee S, Mukherjee S, Chowdhury S (2016) Oxidative stress in hypothyroid patients and the role of antioxidant supplementation. Indian J Endocrinol Metab 20(5):674–678
Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F (2007) Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115:522–526
Lakshmi LJ, Mohapatra E, Zephy D, Kumari S (2013) Serum lipids and oxidative stress in hypothyroidism. J Adv Res Med Sci 5:63–66
Haribabu A, Reddy VS, Pallavi CH, Bitla AR, Sachan A, Pullaiah P, Suresh V, Rao PV, Suchitra MM (2013) Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine 44:152–157
Mancini A, Segni CD, Raimondo S, Olivieri G, Silvestrini A, Meucci E, Currò. D.(2016).Thyroid hormones, oxidative stress, and inflammation. Mediat Inflamm. https://doi.org/10.1155/2016/6757154
Erdogan M, Kösenli A, Ganidagli S, Kulaksizoglu M (2012) Characteristics of anemia in subclinical and overt hypothyroid patients. Endocr J 59:213–220
Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B (1996) Studies on the immunomodulatory effects of ashwagandha. J Ethnopharmacol 50:5069–5076
Tian J, Cai T, Yuan Z, Wang H, Liu L, Haas M, Maksimova E, Huang XY, Xie ZJ (2006) Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell 17:317–326
Dixon MF, Nimmo J, Prescott LF (1971) Experimental paracetamol-induced hepatic necrosis: a histopathological study. J Pathol 103:225–229
Masuda Y, Yano I, Sumida S, Murano T (1975) Studies on the function of cell membrane 10th Report: effects of CCl4 on the marker enzyme activities and fine structures of rat liver plasma membranes and microsomes in vitro. J Pharmacol, 25,151–160
Tayde PS, Bhagwat NM, Sharma P, Sharma B, Dalwadi PP, Sonawane A, Subramanyam A, Chadha M, Varthakavi PK (2017) Hypothyroidism and depression: are cytokines the link? Indian J Endocrinol Metab 21(6):886–892
Türemen EE, Çetinarslan B, Sahin T, Cantürk Z, Tarkun I (2011) Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J 58:349–354
Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L (2010) Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6(2):71–82
Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK (2008) Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 16(10):2323–2330
Pucci E, Chiovato L, Pinchera A (2000) Thyroid and lipid metabolism. Intl J Obes 24(Suppl. 2):S109–S112
Siemińska L, Wojciechowska C, Walczak K, Borowski A, Marek B, Nowak M, Kajdaniuk D, Foltyn W, Kos-Kudła B (2015) Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol 66(5):394–403
Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ (1993) Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: a cohort study. Ann Intern Med 118:424–428
Carrion AF, Czul F, Arosemena LR, Selvaggi G, Garcia MT, Tekin A, Tzakis AG, Martin P, Ghanta RK (2010) Propylthiouracil-induced acute liver failure: role of liver transplantation. Int J Endocrinol. https://doi.org/10.1155/2010/910636
Sarandol E, Tas S, Dirican M, Serdar Z (2005) Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 23:1–8
Devkar ST, Badhe YS, Jagtap SD, Hedge MV (2012) Quantification of major bioactive withanolides in Withania somnifera (ashwagandha) roots by HPTLC for rapid validation of Ayurvedic products. J Planar Chromatogr 25:290–294
Alam N, Hossain M, Khalil MI, Moniruzzaman M, Sulaiman SA, Gan SH (2011) High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysis. BMC Complement Altern Med 11:article 65,. https://doi.org/10.1186/1472-6882-11-65
Saravanan G, Prakash J (2004) Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J Ethnopharmacol 94(1):155–158
Jain R, Kachhwaha S, Kothari SL (2012) Phytochemistry, pharmacology, and biotechnology of Withania somnifera and Withania coagulans: a review. J Med Plants Res 6:5388–5399
Uddin Q, Samiulla L, Singh VK, Jamil SS (2012) Phytochemical and pharmacological profile of Withania somnifera Dunal: a review. J Appl Pharm Sci 02(01):170–175
Gupta V, Keshari BB (2013) Withania coagulans Dunal (Paneer Doda): a review. Int J Ayurvedic Herb Med 3:1330–1336
Lee W, Kim TH, Ku SK, Min KJ, Lee HS, Kwon TK, Bae JS (2012) Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol Appl Pharmacol 262(1):91–98
Mathur D, Agrawal RC (2013) Anticarcinogenic potential of Withania coagulans fruit against skin papilomagenesis in Swiss albino mice. Rec Res Sci Technol 5:1–4
Li X, Zhu F, Jiang J, Sun C, Wang X, Shen M, Tian R, Shi C, Xu M, Peng F (2015) Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3 K/AKT pathway in human pancreatic cancer cells. Cancer Lett 357(1):219–230
Agarwal R, Diwanay S, Patki P, Patwardhan B (1999) Studies on immunomodulatory activity of Withania somnifera (ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol 67(1):27–35
Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, Bansal P, Saxena A, Arya DS (2004) Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem 260(1–2):39–47
Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, Hoda MN, Islam F (2005) Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 24(3):137–147
Kar A, Panda S (2005) Plant extracts in the regulation of hypothyroidism. In: Sharma SK, Govil JN, Singh VK (eds) Recent progress in medicinal plants. Studium Press, Texas, pp 419–426
Panda S, Kar A (1999) Withania somnifera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. J Ethnopharmacol 67(2):233–239
Jatwa R, Kar A (2009) Amelioration of metformin-induced hypothyroidism by Withania somnifera and Bauhinia purpurea extracts in Type 2 diabetic mice. Phytother Res 23(8):1140–1145
Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, Ruiz A, Zhang L, Hanson AD, Conner BP, Rougas J, Pribluda VS (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7(2):115–122
Jackson SS, Oberley C, Hooper CP, Grindle K, Wuerzberger-Davis S, Wolff J, McCool K, Rui L, Miyamoto S (2015) Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-kappa B signaling. Exp Cell Res 331(1):58–72
Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226(1):205–218.
Devika PT, Prince PSM (2008) Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study. Pharmacol Res 57(5):351–357
Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S, Sengottuvelu S (2013) Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int J Cardiol 165(3):494–498
Alam N, Hossain M, Mottalib MA, Sulaiman SA, Gan SH, Khalil MI (2012) Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities. BMC Complement Altern Med. https://doi.org/10.1186/1472-6882-12-175
Ahmed W, Mofed D, Zekri AR, El-Sayed N, Rahouma M, Sabet S (2018) Antioxidant activity and apoptotic induction as mechanisms of action of Withania somnifera (ashwagandha) against a hepatocellular carcinoma cell line. J Int Med Res 46(4):1358–1369
Acknowledgements
The authors would like to thank the authorities of the National Research Centre, Giza, Egypt, for providing the facilities and supporting by the fund (Project Code: 11010331) to carry out this work.
Funding
This study was funded by the National Research Centre, Giza, Egypt (Grant Number: 11010331).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Khaled G. Abdel-Wahhab has received research a grant from National Research Centre, Cairo, Egypt. The authors declare that they have no conflict of interest.
Ethical approval
All animals received human care in compliance with the standard institutional criteria for the care and use of experimental animals according to the National Research Centre ethical committee (FWA 00014747).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abdel-Wahhab, K.G., Mourad, H.H., Mannaa, F.A. et al. Role of ashwagandha methanolic extract in the regulation of thyroid profile in hypothyroidism modeled rats. Mol Biol Rep 46, 3637–3649 (2019). https://doi.org/10.1007/s11033-019-04721-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-019-04721-x